Table 2 Assessment of antibiotics with activity against MRSA according to clinical data
Antibiotic | Randomized controlled studies | Eradication rate (%) | Eradication rate (n) | reference | Toxicity in on label use | Daily cost |
|---|---|---|---|---|---|---|
Linezolid | Yes | 85,4 | 205/240 | [35] | + | +++ |
Tigecycline | Yes | 78,1 | 25/32 | [9] | + | +++ |
Daptomycin | Yes | 75 | 21/28 | [10] | + | +++ |
Vancomycin | Yes | 68,8 | 152/221 | [35] | ++ | ++ |
TMP-SMX | No | 53 | 26/49 | [64] | + | + |
Rifampicin | No | 53 | 26/49 | [64] | + | + |
Fosfomycin | No | n.a. | n.a. | n.a. | + | + |
Clindamycin | No | n.a. | n.a. | n.a. | + | + |
Quino./dalfo | No | n.a. | n.a. | n.a. | +++ | +++ |